Health Worker Influenza Vaccination Programs: A Key to Pandemic Preparedness and Effective COVID-19 Vaccine Deployment in Low- and Middle-Income Countries
Countries with established seasonal influenza vaccination programs were significantly better prepared to deploy COVID-19 vaccines.
News
Policy & Recommendations
Europe strengthens lab defences against key pathogens
ESWI Chair Colin Russell was featured in a Medscape article on the EU reference laboratories aiming to improve disease surveillance data, including respiratory viruses.
World Immunization Week 2026
Under the theme, “For every generation, vaccines work”, the World Immunization Week will promote how vaccines have safely protected people, families and communities for generations .
News
Policy & Recommendations
The European Commission authorised the first combined COVID-19 and influenza vaccine for people 50 years and older
The EC has recently published on the Union Register of medicinal products the decision granting EU marketing authorisation for mCombriax, an mRNA vaccine to protect people aged 50 years and older against COVID-19 and seasonal influenza.
News
Policy & Recommendations
Council recommendation on the value of immunisation against respiratory infections: a step towards an EU Respiratory Health Plan?
Hosted by Cypriot MEP Michalis Hadjipantela at the European Parliament, the event brought together experts and representatives from various EU institutions.
News
Policy & Recommendations
Respiratory infections and long-term illness: a two-way street
The IDC kick-off meeting on 5 March was featured on the Vaccines Today news website.
Adenoviral Inciting Antigen and Somatic Hypermutation in VITT
Vaccine-induced immune thrombocytopenia and thrombosis (VITT) is a rare prothrombotic complication that occurs after adenoviral vector–based vaccination against coronavirus disease 2019.
Adult obesity and risk of severe infections: a multicohort study with global burden estimates
Adult obesity has been linked to specific infections, but evidence across the full spectrum of infectious diseases remains scarce.